16.20 | 13.20 – Chair’s Closing Remarks: What’s Next For Liquid Biopsy in Precision Oncology

Time: 4:20 pm
day: Day Two


  • What new opportunities are there for liquid biopsies to further precision therapy approaches in oncology
  • What does clinical evidence show us in terms of liquid biopsy replacing the ‘gold standard’ become a reality in some instances – (Drawing on case study examples)
  • Reflecting on the core challenges industry needs to solve